vs
GRAFTECH INTERNATIONAL LTD（EAF）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
GRAFTECH INTERNATIONAL LTD的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.5倍（$116.5M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -13.2%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-39.3M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -7.7%）
格瑞泰克国际有限公司是石墨电极与石油焦生产商，其产品是电弧炉炼钢及其他金属生产的核心原材料。公司总部位于俄亥俄州布鲁克林海茨，在法国加来、西班牙潘普洛纳、墨西哥蒙特雷以及美国宾夕法尼亚州圣玛丽斯均设有生产基地。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
EAF vs PBYI — 直观对比
营收规模更大
EAF
是对方的1.5倍
$75.5M
营收增速更快
PBYI
高出41.0%
-13.2%
自由现金流更多
PBYI
多$53.6M
$-39.3M
两年增速更快
PBYI
近两年复合增速
-7.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $116.5M | $75.5M |
| 净利润 | $-65.1M | — |
| 毛利率 | -20.9% | 69.3% |
| 营业利润率 | -33.6% | 22.7% |
| 净利率 | -55.9% | — |
| 营收同比 | -13.2% | 27.7% |
| 净利润同比 | -31.6% | — |
| 每股收益（稀释后） | $-6.86 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EAFPBYI
| Q4 25 | $116.5M | $75.5M | ||
| Q3 25 | $144.0M | $54.5M | ||
| Q2 25 | $131.8M | $52.4M | ||
| Q1 25 | $111.8M | $46.0M | ||
| Q4 24 | $134.2M | $59.1M | ||
| Q3 24 | $130.7M | $80.5M | ||
| Q2 24 | $137.3M | $47.1M | ||
| Q1 24 | $136.6M | $43.8M |
净利润EAFPBYI
| Q4 25 | $-65.1M | — | ||
| Q3 25 | $-28.5M | $8.8M | ||
| Q2 25 | $-86.9M | $5.9M | ||
| Q1 25 | $-39.4M | $3.0M | ||
| Q4 24 | $-49.5M | — | ||
| Q3 24 | $-36.1M | $20.3M | ||
| Q2 24 | $-14.8M | $-4.5M | ||
| Q1 24 | $-30.9M | $-4.8M |
毛利率EAFPBYI
| Q4 25 | -20.9% | 69.3% | ||
| Q3 25 | 7.2% | 77.7% | ||
| Q2 25 | 0.0% | 76.5% | ||
| Q1 25 | -1.5% | 77.1% | ||
| Q4 24 | -7.8% | 76.4% | ||
| Q3 24 | -9.2% | 63.9% | ||
| Q2 24 | 2.9% | 77.4% | ||
| Q1 24 | -1.0% | 75.5% |
营业利润率EAFPBYI
| Q4 25 | -33.6% | 22.7% | ||
| Q3 25 | -3.6% | 17.6% | ||
| Q2 25 | -11.0% | 12.7% | ||
| Q1 25 | -16.3% | 8.7% | ||
| Q4 24 | -18.6% | 22.6% | ||
| Q3 24 | -20.1% | 27.4% | ||
| Q2 24 | -2.0% | -4.6% | ||
| Q1 24 | -15.6% | -5.3% |
净利率EAFPBYI
| Q4 25 | -55.9% | — | ||
| Q3 25 | -19.8% | 16.2% | ||
| Q2 25 | -65.9% | 11.2% | ||
| Q1 25 | -35.2% | 6.5% | ||
| Q4 24 | -36.9% | — | ||
| Q3 24 | -27.6% | 25.2% | ||
| Q2 24 | -10.7% | -9.6% | ||
| Q1 24 | -22.6% | -11.0% |
每股收益（稀释后）EAFPBYI
| Q4 25 | $-6.86 | $0.26 | ||
| Q3 25 | $-1.10 | $0.17 | ||
| Q2 25 | $-0.34 | $0.12 | ||
| Q1 25 | $-0.15 | $0.06 | ||
| Q4 24 | $-3.51 | $0.40 | ||
| Q3 24 | $-1.40 | $0.41 | ||
| Q2 24 | $-0.06 | $-0.09 | ||
| Q1 24 | $-0.12 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | $1.1B | $22.7M |
| 股东权益账面价值 | $-259.6M | $130.3M |
| 总资产 | $1.0B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资EAFPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | $120.7M | $96.8M | ||
| Q1 24 | $165.2M | $107.2M |
总债务EAFPBYI
| Q4 25 | $1.1B | $22.7M | ||
| Q3 25 | $1.1B | $34.0M | ||
| Q2 25 | $1.1B | $45.3M | ||
| Q1 25 | $1.1B | $56.7M | ||
| Q4 24 | $1.1B | $68.0M | ||
| Q3 24 | $929.5M | $79.3M | ||
| Q2 24 | $928.2M | $90.7M | ||
| Q1 24 | $926.9M | $102.0M |
股东权益EAFPBYI
| Q4 25 | $-259.6M | $130.3M | ||
| Q3 25 | $-194.4M | $115.3M | ||
| Q2 25 | $-168.4M | $104.7M | ||
| Q1 25 | $-105.3M | $97.1M | ||
| Q4 24 | $-78.9M | $92.1M | ||
| Q3 24 | $-9.0M | $71.1M | ||
| Q2 24 | $16.2M | $48.5M | ||
| Q1 24 | $37.6M | $51.0M |
总资产EAFPBYI
| Q4 25 | $1.0B | $216.3M | ||
| Q3 25 | $1.1B | $202.9M | ||
| Q2 25 | $1.1B | $194.9M | ||
| Q1 25 | $1.2B | $196.2M | ||
| Q4 24 | $1.2B | $213.3M | ||
| Q3 24 | $1.1B | $220.7M | ||
| Q2 24 | $1.2B | $205.0M | ||
| Q1 24 | $1.2B | $214.1M |
负债/权益比EAFPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | 57.16× | 1.87× | ||
| Q1 24 | 24.64× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-20.9M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-39.3M | $14.4M |
| 自由现金流率自由现金流/营收 | -33.7% | 19.1% |
| 资本支出强度资本支出/营收 | 15.8% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-120.5M | $41.7M |
8季度趋势，按日历期对齐
经营现金流EAFPBYI
| Q4 25 | $-20.9M | $14.4M | ||
| Q3 25 | $24.7M | $9.7M | ||
| Q2 25 | $-53.2M | $14.1M | ||
| Q1 25 | $-32.2M | $3.6M | ||
| Q4 24 | $-26.4M | $15.6M | ||
| Q3 24 | $23.7M | $11.0M | ||
| Q2 24 | $-36.9M | $1.0M | ||
| Q1 24 | $-530.0K | $11.2M |
自由现金流EAFPBYI
| Q4 25 | $-39.3M | $14.4M | ||
| Q3 25 | $18.4M | $9.7M | ||
| Q2 25 | $-57.1M | $14.1M | ||
| Q1 25 | $-42.5M | $3.6M | ||
| Q4 24 | $-39.2M | $15.6M | ||
| Q3 24 | $19.7M | $11.0M | ||
| Q2 24 | $-43.8M | $1.0M | ||
| Q1 24 | $-11.0M | — |
自由现金流率EAFPBYI
| Q4 25 | -33.7% | 19.1% | ||
| Q3 25 | 12.8% | 17.7% | ||
| Q2 25 | -43.3% | 26.8% | ||
| Q1 25 | -38.0% | 7.7% | ||
| Q4 24 | -29.2% | 26.4% | ||
| Q3 24 | 15.1% | 13.7% | ||
| Q2 24 | -31.9% | 2.1% | ||
| Q1 24 | -8.1% | — |
资本支出强度EAFPBYI
| Q4 25 | 15.8% | 0.0% | ||
| Q3 25 | 4.4% | 0.0% | ||
| Q2 25 | 3.0% | 0.0% | ||
| Q1 25 | 9.2% | 0.1% | ||
| Q4 24 | 9.5% | 0.0% | ||
| Q3 24 | 3.1% | 0.0% | ||
| Q2 24 | 5.1% | 0.0% | ||
| Q1 24 | 7.7% | 0.0% |
现金转化率EAFPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EAF
| Graphite Electrodes | $107.0M | 92% |
| By Products And Other | $9.4M | 8% |
PBYI
暂无分部数据
